• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Endeavor: Alternative Drug-Eluting Stent?

0
  • by alexperjescuadmin
  • in Cardiovascular · ESC 2005
  • — 12 Sep, 2005
Endeavor: Alternative Drug-Eluting Stent?
AudioMedica News
Endeavor: Alternative Drug-Eluting Stent?
Endeavor: Alternative Drug-Eluting Stent?
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-58"/>
Jean Fajadet
Jean Fajadet

The ESC heard the latest on the Endeavor stent, which elutes the sirolimus analogue ABT-578. Jean Fajadet from Toulouse told Audio Medica about the findings from ENDEAVOR II study of around 1200 patients.
[audio:https://www.audiomedica.com/podcasting/17.Jean_Fajadet-Endeavour-2_study.mp3]

Click here for all the interviews from ESC 2005

Share

Tags: endeavorstents

You may also like...

  • TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention? TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention? 5 Nov, 2007
  • Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results 6 Nov, 2007
  • Audio Journal of Cardiovascular Medicine: September 3rd 2006 Audio Journal of Cardiovascular Medicine: September 3rd 2006 3 Sep, 2006
  • Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI 5 Nov, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Europe Leaps to Action on Heart-Unfriendly Lifestyles
  • Next story Drug-Coated Balloon for In-Stent Restenosis: First Experience
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Cabozantinib Improved Hepatocellular Carcinoma…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Ribociclib Aids First-Line Endocrine Therapy in…
  • Home
  • Cardiovascular
  • Endeavor: Alternative Drug-Eluting Stent?

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.